Michael J. Cima is a professor of materials science and engineering. He earned a BS in chemistry in 1982 (Phi Beta Kappa) and a PhD in chemical engineering in 1986, both from the University of California at Berkeley.
Cima joined the MIT faculty in 1986 as an assistant professor. He was promoted to full pzrofessor in 1995. He was elected a fellow of the American Ceramics Society in 1997. He now holds the Sumitomo Electric Industries professorship at MIT. He is author or co-author of more than 190 peer-reviewed scientific publications, 45 patents, and is a recognized expert in the field of materials processing.
Cima is actively involved in materials and engineered systems for improvement human health such treatments for cancer, metabolic diseases, trauma and urological disorders. Cima's research concerns advanced forming technology for complex macro and micro devices, colloid science, MEMS and other micro components for medical devices that are used for drug delivery and diagnostics, as well as high-throughput development methods for formulations of materials and pharmaceutical formulations. He is a co-inventor of MIT’s three-dimensional printing process. His research has led to the development of chemically derived epitaxial oxide films for HTSC coated conductors. He and collaborators are developing implantable MEMS devices for unprecedented control in the delivery of pharmaceuticals and implantable diagnostic systems.
Finally, through his consulting work, he has been a major contributor to the development of high-throughput systems for discovery of novel crystal forms and formulations of pharmaceuticals. Cima also has extensive entrepreneurial experience. He is co-founder and a director of MicroChips Inc., a developer of microelectronic-based drug-delivery and diagnostic systems. He took two sabbaticals to act as senior consultant and management team member at Transform Pharmaceuticals Inc., a company that he helped start and which was ultimately acquired by Johnson & Johnson. He is a co-founder and director at T2 Biosystems, a medical-diagnostics company. Most recently, Cima co-founded Entra Pharmaceuticals, a specialty pharmaceutical company, and Taris Biomedical, a urology products company.